Home | Substack

It Works Too Well. Early research suggests that psilocybin therapy can cause remission of depressive symptoms in one to three sessions. Contrast that with SSRIs like Prozac, which patients take (and insurance companies pay for) for the rest of their lives. That means that there’s little recurring revenue, so COMPASS needs to convince the payers to ... See more

It is known that the likelihood of long-term therapeutic gains increases with the likelihood of the subject having a mystical experience, prima facie evidence favoring a critical role for subjectivity. It is precisely the high emotional impact of the memories of the vivid and highly unusual psychedelic experience that serves as the primary source o

... See more